EDITORS EMULSION 1Sep2018

The IPC, an Autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India, created to set standards of drugs in the country with its basic function to update regularly the standards of drugs commonly required for treatment of diseases prevailing, had our founder director Bejon Misra over as chief guest on our Independence Day. Read more on this and how India is witnessing an alarming rise in the rate of carbapenem-resistant bacteria underlining the need for enhanced antimicrobial surveillance and prevention of antibiotic misuse in PSM India capsules.

The Government of India is introducing various constructive laws and policies along with the high court in matters relating to clinical establishments violating rules, printing of generic name in double the font size than brand name, price-ceiling list, over dependence on China for import of bulk drugs, among others. Get an insight into this under Drug laws and Policy Injections.

This issue of The Prescription holds some interesting articles in Pharma Injections on how fixed dose combo ban hits the retail Pharma business and how the rising cost of Chinese raw materials is eating into margins of Indian Pharma companies. While you review the list on new drugs approved till date under the section named Drug Dopes, catch up on spurious drugs being unearthed in India and the world over in National and Global Injections respectively.

We constantly endeavour not only to collate important information from the health and medicine world but also to create a connect with consumers all over. We welcome articles and write ups from our readers and are glad to feature them under the section titled Subscriber’s Symptoms. This issue features a contribution by a home maker, Ms. K. Saundarya from Chennai on how to be careful with “Alternative Therapies”. Mark your calendar with the upcoming events listed in our newsletter and remember to take your laughter dose in the end.

Do not hesitate to mail your comments on this newsletter to help us improve further. We appreciate your support and trust in us and are happy to have you as our loyal reader. Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@patientsafetyaccess.org .

You may find our previous issues on our website patientsafetyaccess.org or in the NEWS ARCHIVE section of every  issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook .

Stay Healthy. Stay Safe.

Pooja Mishra Khaitan

Editor-in-Chief,

The Prescription